Articles

Effective stats are new hurdle for U.S. drugmakers

WellPoint Inc.'s announcement of comparative effectiveness research guidelines last week marks a new era for U.S. drugmakers.
The Indianapolis-based health insurer will use studies that compare the effectiveness of one drug against another as a complement
to typical clinical trial research that compares a drug against a placebo sugar pill.

Read More

WellPoint meeting ends abruptly as Bush collapses

Board member William “Bucky” Bush, uncle of former President George W. Bush, appeared OK after a shortened meeting in which
shareholders approved
a “say-on-pay” proposal. Protesters gathered outside WellPoint’s headquarters after the meeting.

Read More

Q&A

Joe Guzman is a co-founder of Indianapolis-based Ascend USA, the new trade adopted after Guzman merged his
benefits brokerage, Benefits Strategies Inc., with benefits business Steven Goodin. The eight-person firm expects to hire
as many 15 new employees in the next year. Those workers will help Ascend diversify from health benefits into brokering commercial
insurance products.

Read More

Study: Quality, costs better at big practices

As physician mergers increase in Indianapolis, a new study has determined that quality at large, multispecialty practices is at
least 5 percent higher and costs are 3.6 percent lower than at small group practices.

Read More

Clarian Health sued over bills for services

The lawsuit filed this week in Marion Superior Court claims Clarian Health charges uninsured patients—or those receiving
treatments not covered by their insurance—unreasonably high prices.

Read More

Q&A

Dr. Stanley Adkins is chief medical officer of Indianapolis-based AmeriVeriCR, a startup that uses software to review medical
claims for errors. With health care reform and a new, larger set of
diagnosis codes phasing in over the next few years, AmeriVeri is betting that demand for its service will increase.

Read More

Anthem Blue Cross postponing rate hike again

In January, Anthem Blue Cross notified many individual policyholders that their rates would rise as much as 39 percent March
1. After a public outcry, the company announced a two-month delay. Now that is on hold, too.

Read More